Saturday, September 9, 2017

23andMe’s second act sits squarely in drug research and development

by Sarah Buhr via Tech News http://ift.tt/2xlZwxg


http://ift.tt/2whMYBX
Posted by at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)